User profiles for "author:Shamshad Ali"
Dr. Shamshad AliAssistant Professor, BUET Khuzdar Verified email at student.muet.edu.pk Cited by 661 |
Recent development in separators for high‐temperature lithium‐ion batteries
Lithium‐ion batteries (LIBs) are promising energy storage devices for integrating renewable
resources and high power applications, owing to their high energy density, light weight, high …
resources and high power applications, owing to their high energy density, light weight, high …
[HTML][HTML] Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study
CF Levenback, S Ali, RL Coleman… - Journal of Clinical …, 2012 - ncbi.nlm.nih.gov
Lymphatic Mapping and Sentinel Lymph Node Biopsy in Women With Squamous Cell
Carcinoma of the Vulva: A Gynecologic Oncology Group Study - PMC Back to Top Skip to main …
Carcinoma of the Vulva: A Gynecologic Oncology Group Study - PMC Back to Top Skip to main …
Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic …
PG Rose, S Ali, E Watkins, JT Thigpen… - Journal of clinical …, 2007 - ascopubs.org
Purpose We report the long-term survival and toxicity of a randomized phase III study
comparing cisplatin alone with cisplatin, flurouracil, and hydroxyurea versus hydroxyurea …
comparing cisplatin alone with cisplatin, flurouracil, and hydroxyurea versus hydroxyurea …
A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic …
DH Moore, S Ali, WJ Koh, H Michael, MN Barnes… - Gynecologic …, 2012 - Elsevier
OBJECTIVES: To determine the efficacy and toxicity of radiation therapy and concurrent
weekly cisplatin chemotherapy in achieving a complete clinical and pathologic response …
weekly cisplatin chemotherapy in achieving a complete clinical and pathologic response …
[HTML][HTML] Clinicopathologic significance of mismatch repair defects in endometrial cancer: an NRG oncology/gynecologic oncology group study
DS McMeekin, DL Tritchler, DE Cohn… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
Purpose The clinicopathologic significance of mismatch repair (MMR) defects in
endometrioid endometrial cancer (EEC) has not been definitively established. We undertook …
endometrioid endometrial cancer (EEC) has not been definitively established. We undertook …
[HTML][HTML] Combined microsatellite instability, MLH1 methylation analysis, and immunohistochemistry for Lynch syndrome screening in endometrial cancers from …
PJ Goodfellow, CC Billingsley, HA Lankes… - Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
Purpose The best screening practice for Lynch syndrome (LS) in endometrial cancer (EC)
remains unknown. We sought to determine whether tumor microsatellite instability (MSI) …
remains unknown. We sought to determine whether tumor microsatellite instability (MSI) …
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic …
G Thomas, S Ali, FJP Hoebers, KM Darcy… - Gynecologic …, 2008 - Elsevier
PURPOSE: To determine whether maintaining HGB levels≥ 12.0 g/dL with recombinant
human erythropoietin (R-HUEPO) compared to “standard” treatment (transfusion for HGB≤ …
human erythropoietin (R-HUEPO) compared to “standard” treatment (transfusion for HGB≤ …
Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial
FB Stehman, S Ali, HM Keys, LI Muderspach… - American journal of …, 2007 - Elsevier
OBJECTIVE: The objective of the study was to confirm that concurrent cisplatin (CT) with
radiation therapy (RT) is associated with improved long-term progression-free survival (PFS) …
radiation therapy (RT) is associated with improved long-term progression-free survival (PFS) …
[HTML][HTML] Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical …
PA DiSilvestro, S Ali, PS Craighead… - Journal of clinical …, 2014 - ncbi.nlm.nih.gov
Purpose This prospective, randomized phase III intergroup trial of the Gynecologic Oncology
Group and National Cancer Institute of Canada Clinical Trials Group was designed to test …
Group and National Cancer Institute of Canada Clinical Trials Group was designed to test …
Zein/cellulose acetate hybrid nanofibers: Electrospinning and characterization
Protein based scaffolds are preferred for tissue engineering and other biomedical
applications owing to their unique properties. Zein, a hydrophobic protein, is a promising …
applications owing to their unique properties. Zein, a hydrophobic protein, is a promising …